Shujin Li , Jiancheng Mou , Guoxin Huang , Xin Zeng , Yuxiao Mu , Weimin Hong , Xuli Meng , Qinghui Zheng , Da Qian
{"title":"Breast Cancer in Working-Age Men: A Population-Based Investigation of Global, Regional, and National Disease Burdens Between 1990 and 2021","authors":"Shujin Li , Jiancheng Mou , Guoxin Huang , Xin Zeng , Yuxiao Mu , Weimin Hong , Xuli Meng , Qinghui Zheng , Da Qian","doi":"10.1016/j.clbc.2025.07.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The breast cancer (BC) disease burden in working-age men was investigated between 1990 and 2021.</div></div><div><h3>Methods</h3><div>Age-standardized incidence rates (ASIRs), prevalence rates ASPRs), and death rates (ASDRs), as well as age-standardized disability-adjusted life years rate (DALYs) on global, regional, and national levels between 1990 and 2021, were determined to assess the BC disease burden in working-age men (aged 15-64 years), together with risk factor and health inequality analyses.</div></div><div><h3>Results</h3><div>Globally, the ASIR, ASPR, ASDR, and age-standardized DALY rate in 2021 were 0.77 per 100,000 males (0.46‒0.99), 6.34 per 100,000 males (3.97‒8.02), 0.22 per 100,000 males (0.14‒0.28), and 8.75 per 100,000 males (5.58‒11.40), respectively. The burden of disease varied among regions and countries. Risk factor analysis revealed a marked influence of diets high in red meat on the ASDR and age-standardized DALY rate. Cross-national social inequality analysis identified marked inequalities, both relative and absolute, in the disease burden among regions, with higher burdens found in countries with lower sociodemographic indices.</div></div><div><h3>Conclusions</h3><div>The BC disease burden has escalated in men of working age, accompanied by a decline in life expectancy since the 1990s and increases in associated deaths and DALYs. Low-income regions exhibited a more substantial burden compared to high-income regions. The key to reducing the disease burden lies in enhancing national economic strength, with improvements in medical systems and the development of targeted clinical guidelines.</div></div>","PeriodicalId":10197,"journal":{"name":"Clinical breast cancer","volume":"25 7","pages":"Pages 680-692"},"PeriodicalIF":2.5000,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical breast cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1526820925002083","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The breast cancer (BC) disease burden in working-age men was investigated between 1990 and 2021.
Methods
Age-standardized incidence rates (ASIRs), prevalence rates ASPRs), and death rates (ASDRs), as well as age-standardized disability-adjusted life years rate (DALYs) on global, regional, and national levels between 1990 and 2021, were determined to assess the BC disease burden in working-age men (aged 15-64 years), together with risk factor and health inequality analyses.
Results
Globally, the ASIR, ASPR, ASDR, and age-standardized DALY rate in 2021 were 0.77 per 100,000 males (0.46‒0.99), 6.34 per 100,000 males (3.97‒8.02), 0.22 per 100,000 males (0.14‒0.28), and 8.75 per 100,000 males (5.58‒11.40), respectively. The burden of disease varied among regions and countries. Risk factor analysis revealed a marked influence of diets high in red meat on the ASDR and age-standardized DALY rate. Cross-national social inequality analysis identified marked inequalities, both relative and absolute, in the disease burden among regions, with higher burdens found in countries with lower sociodemographic indices.
Conclusions
The BC disease burden has escalated in men of working age, accompanied by a decline in life expectancy since the 1990s and increases in associated deaths and DALYs. Low-income regions exhibited a more substantial burden compared to high-income regions. The key to reducing the disease burden lies in enhancing national economic strength, with improvements in medical systems and the development of targeted clinical guidelines.
期刊介绍:
Clinical Breast Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer. Specific areas of interest include clinical research reports from various therapeutic modalities, cancer genetics, drug sensitivity and resistance, novel imaging, tumor genomics, biomarkers, and chemoprevention strategies.